ATE345699T1 - Nahrungsergänzung mit schlankheitseffekt - Google Patents
Nahrungsergänzung mit schlankheitseffektInfo
- Publication number
- ATE345699T1 ATE345699T1 AT01949869T AT01949869T ATE345699T1 AT E345699 T1 ATE345699 T1 AT E345699T1 AT 01949869 T AT01949869 T AT 01949869T AT 01949869 T AT01949869 T AT 01949869T AT E345699 T1 ATE345699 T1 AT E345699T1
- Authority
- AT
- Austria
- Prior art keywords
- dietary supplement
- slimming effect
- slimming
- effect
- cardio
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 1
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 235000019192 riboflavin Nutrition 0.000 abstract 1
- 239000002151 riboflavin Substances 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Confectionery (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001RM000044A ITRM20010044A1 (it) | 2001-01-29 | 2001-01-29 | Integratore alimentare ad effetto dimagrante. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE345699T1 true ATE345699T1 (de) | 2006-12-15 |
Family
ID=11455161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01949869T ATE345699T1 (de) | 2001-01-29 | 2001-06-13 | Nahrungsergänzung mit schlankheitseffekt |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8207109B2 (de) |
| EP (1) | EP1355540B1 (de) |
| AT (1) | ATE345699T1 (de) |
| AU (1) | AU2001270980B2 (de) |
| CA (1) | CA2434482C (de) |
| CY (1) | CY1106031T1 (de) |
| DE (1) | DE60124769T2 (de) |
| DK (1) | DK1355540T3 (de) |
| ES (1) | ES2271042T3 (de) |
| HU (1) | HU228455B1 (de) |
| IT (1) | ITRM20010044A1 (de) |
| MX (1) | MXPA03006503A (de) |
| PL (1) | PL201733B1 (de) |
| PT (1) | PT1355540E (de) |
| WO (1) | WO2002060278A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005031705A1 (de) * | 2005-07-05 | 2007-01-18 | Henkel Kgaa | Mittel, enthaltend L-Carnitin oder L-Carnitinderivate und mindestens eine weitere Substanz ausgewählt aus Taurin und dessen Derivaten und mindestens einem Wirkstoff, erhältlich aus Pflanzen der Gattung Echinacea |
| EA023913B1 (ru) | 2009-05-11 | 2016-07-29 | БЕРГ ФАРМА ЭлЭлСи | Способы лечения метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния |
| DE102009044975A1 (de) | 2009-07-23 | 2011-01-27 | Henkel Ag & Co. Kgaa | Verwendung von Carnitin und Dihydroquercetin zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses |
| DE102009044964A1 (de) | 2009-09-24 | 2011-03-31 | Henkel Ag & Co. Kgaa | Verwendung einer Kombination aus Carnitin und/oder eines Carnitin-Derivats mit Purin und/oder einem Purin-Derivat zur Beeinflussung des natürlichen Pigmentierungsprozesses |
| CN103608323B (zh) | 2011-04-04 | 2016-08-17 | 博格有限责任公司 | 治疗中枢神经系统肿瘤的方法 |
| WO2014045065A2 (en) * | 2012-09-22 | 2014-03-27 | Bslim Holdings Limited | Dietary compositions and their uses |
| GB201304112D0 (en) * | 2013-03-07 | 2013-04-24 | Univ Nottingham | Modulation of energy expenditure |
| EP2983654B1 (de) | 2013-04-08 | 2025-11-12 | BPGbio, Inc. | Behandlung von krebs mit coenzym-q10-kombinationstherapien |
| WO2015035094A1 (en) | 2013-09-04 | 2015-03-12 | Berg Llc | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
| US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
| EP3368498A4 (de) | 2015-10-27 | 2019-06-12 | Cytozyme Animal Nutrition, Inc. | Tiernährstoffzusammensetzungen und zugehörige verfahren |
| US20170189350A1 (en) | 2015-11-16 | 2017-07-06 | Berg Llc | Methods of treatment of temozolomide-resistant glioma using coenzyme q10 |
| JP7305088B2 (ja) * | 2019-03-06 | 2023-07-10 | 源至技術有限公司 | 動物用飼料添加物の調製にγ－第四級アンモニウム酪酸エステル化合物の適用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4298601A (en) * | 1972-03-06 | 1981-11-03 | Technutra, S.A. | Method and formulations for the treatment of obesity |
| EP0150688B1 (de) | 1983-12-28 | 1987-04-22 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Salze von L-Carnitin und Alkanoyl-L-Carnitinen sowie Verfahren zur Herstellung derselben |
| ZA904021B (en) * | 1989-11-24 | 1991-02-27 | Van Der Linde Leon | Slimming preparations |
| GB9214247D0 (en) * | 1992-07-04 | 1992-08-19 | Stephan Peter M | Composition for use as a food or food supplement |
| DE4410238A1 (de) * | 1994-03-25 | 1995-09-28 | Beiersdorf Ag | Hautpflegemittel |
| US5626849A (en) * | 1995-06-07 | 1997-05-06 | Reliv International, Inc. | Weight loss composition for burning and reducing synthesis of fats |
| US5998457A (en) * | 1995-10-26 | 1999-12-07 | Avicena Group, Inc. | Creatine analogues for treatment of obesity |
| IT1276253B1 (it) * | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
| CN1122456C (zh) * | 1996-01-31 | 2003-10-01 | 南亚拉巴马医学科学基金会 | 含有天然的还原叶酸盐异构体的食品和维生素制品 |
| AU718308B2 (en) | 1996-05-31 | 2000-04-13 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Stable, non-hygroscopic salts of L(-)carnitine and alkanoyl L(-)carnitines, a process for their preparation and solid, orally administrable compositions containing such salts |
| US5976568A (en) * | 1997-02-21 | 1999-11-02 | Medical Doctors' Research Institute, Inc. | Modular system of dietary supplement compositions for optimizing health benefits and methods |
| AU7828200A (en) | 1999-09-23 | 2001-04-24 | Juvenon Corporation | Nutritional supplement for increased energy and stamina |
| US6562869B1 (en) * | 1999-09-23 | 2003-05-13 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
| IT1307278B1 (it) * | 1999-11-18 | 2001-10-30 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil |
| DE10003493A1 (de) * | 2000-01-27 | 2001-08-09 | Wacker Chemie Gmbh | Verfahren zur Herstellung eines Koezym Q10-/y-Cyclodextrin Komplexes |
| US6277842B1 (en) * | 2000-10-17 | 2001-08-21 | James Alexander Carthron | Dietary supplemental method for fat and weight reduction |
-
2001
- 2001-01-29 IT IT2001RM000044A patent/ITRM20010044A1/it unknown
- 2001-06-13 AT AT01949869T patent/ATE345699T1/de active
- 2001-06-13 US US10/250,361 patent/US8207109B2/en not_active Expired - Fee Related
- 2001-06-13 EP EP01949869A patent/EP1355540B1/de not_active Expired - Lifetime
- 2001-06-13 CA CA002434482A patent/CA2434482C/en not_active Expired - Fee Related
- 2001-06-13 ES ES01949869T patent/ES2271042T3/es not_active Expired - Lifetime
- 2001-06-13 WO PCT/IT2001/000304 patent/WO2002060278A1/en not_active Ceased
- 2001-06-13 PT PT01949869T patent/PT1355540E/pt unknown
- 2001-06-13 MX MXPA03006503A patent/MXPA03006503A/es active IP Right Grant
- 2001-06-13 DE DE60124769T patent/DE60124769T2/de not_active Expired - Lifetime
- 2001-06-13 HU HU0302990A patent/HU228455B1/hu not_active IP Right Cessation
- 2001-06-13 AU AU2001270980A patent/AU2001270980B2/en not_active Ceased
- 2001-06-13 PL PL365253A patent/PL201733B1/pl not_active IP Right Cessation
- 2001-06-13 DK DK01949869T patent/DK1355540T3/da active
-
2007
- 2007-02-20 CY CY20071100222T patent/CY1106031T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM20010044A1 (it) | 2002-07-29 |
| DE60124769D1 (de) | 2007-01-04 |
| DK1355540T3 (da) | 2007-04-02 |
| PL365253A1 (en) | 2004-12-27 |
| WO2002060278A1 (en) | 2002-08-08 |
| HUP0302990A2 (hu) | 2003-12-29 |
| MXPA03006503A (es) | 2004-04-21 |
| CY1106031T1 (el) | 2011-04-06 |
| ES2271042T3 (es) | 2007-04-16 |
| ITRM20010044A0 (it) | 2001-01-29 |
| PL201733B1 (pl) | 2009-05-29 |
| DE60124769T2 (de) | 2007-09-13 |
| EP1355540A1 (de) | 2003-10-29 |
| US8207109B2 (en) | 2012-06-26 |
| PT1355540E (pt) | 2007-01-31 |
| EP1355540B1 (de) | 2006-11-22 |
| HUP0302990A3 (en) | 2005-04-28 |
| AU2001270980B2 (en) | 2007-01-18 |
| HU228455B1 (en) | 2013-03-28 |
| US20040028668A1 (en) | 2004-02-12 |
| CA2434482A1 (en) | 2002-08-08 |
| CA2434482C (en) | 2009-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60124769D1 (de) | Nahrungsergänzung mit schlankheitseffekt | |
| WO2004047269A3 (en) | Flip-flop circuit | |
| WO2006068697A3 (en) | Compositions including iron | |
| PL366401A1 (en) | Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. | |
| IT1318565B1 (it) | Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e. | |
| AU2003295603A8 (en) | Dynamic identification of other users to an online user | |
| AU2002356276A8 (en) | Quinline derivates and their use as mek inhibitors | |
| AU2003252182A8 (en) | Therapeutic treatment for the metabolic syndrome and type 2 diabetes | |
| CA2374333A1 (en) | Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract | |
| PL374082A1 (en) | Carnitine in the treatment of geriatric depression | |
| SI1532141T1 (sl) | 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi | |
| WO2002085341A3 (en) | Composition, containing carnitine and huperzin for the preventionor treatment of learning disorders in children suffering from attention deficit/hyperactive disorder | |
| AU2003268749A1 (en) | Swing table device and exercise appliance using the device | |
| PL372900A1 (en) | Treatment of metabolic syndrome | |
| TH62050S (th) | กระติกน้ำร้อนไฟฟ้า | |
| SI1532124T1 (sl) | Uporaba nitrilnih derivatov kot zdravila | |
| FI5999U1 (fi) | Sisustus- ja leikkielementti | |
| TH21287S1 (th) | ตลับใส่แป้งผัดหน้า | |
| TH67015S (th) | ตลับใส่แป้งผัดหน้า | |
| TH27906S1 (th) | ฐานขาชั้นวาง | |
| TH69606S (th) | ฐานขาชั้นวาง | |
| TH69608S (th) | ฐานขาชั้นวาง | |
| TH27907S1 (th) | ฐานขาชั้นวาง | |
| TW552980U (en) | Wrist ball capable of generating electricity by itself | |
| CA99715S (en) | Trousers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1355540 Country of ref document: EP |